From May 19 to 22, 2026, the 31st edition of Hospitalar – International Fair of Hospital Products, Equipment and Services – was grandly held at the São Paulo Expo. Leveraging the “Made in China” platform, A.H.A INTERNATIONAL Co., Ltd. showcased its self-branded pharmaceutical finished products, attracting numerous professional buyers from Brazil and various Latin American countries for discussions.
Booth No. D-203
A.H.A INTERNATIONAL Co., Ltd. has over 40 years of professional foreign trade experience and resources, operating as a comprehensive enterprise group that integrates specialized international trade with high-end pharmaceutical R&D and manufacturing. The company has successively obtained multiple international certifications, including China Customs AEO Advanced Certification, ISO, Ecovadis (Gold), ESGG, and BRCGS. Its strategic partner, Huayi Pharmaceuticals (Anhui)Co.,Ltd, is the 12th company in China and the first in Anhui Province to pass the EU cGMP certification for oral solid dosage forms, and is recognized as a pioneer in the internationalization of Chinese pharmaceutical finished products. Additionally, the quality testing center of its subsidiary, Anhui Jinlang New Material Technology Co.,Ltd., received CNAS National Laboratory Accreditation in 2026.
As the largest and most influential comprehensive medical and pharmaceutical exhibition in Latin America, this year’s Hospitalar attracted over 1,272 exhibiting companies, 85,000 professional visitors, and industry representatives from 55 countries and regions, covering an exhibition area of 80,000 square meters.
A.H.A INTERNATIONAL Co., Ltd. focuses on core pharmaceutical finished products to meet the diverse needs of the Latin American market, using the exhibition as a bridge to further expand its presence in the region. Brazil is the largest pharmaceutical market in Latin America, with the total trade volume of pharmaceutical products between China and Brazil reaching US$3.91 billion in 2025, indicating vast potential for continued bilateral cooperation. Through its participation in Hospitalar 2026, A.H.A INTERNATIONAL Co., Ltd. further strengthened its brand influence and industry recognition in the Latin American market.